【24h】

Controlled Release of (SBA-15)-Carvedilol Drug

机译:(SBA-15)-卡维地洛药物的控释

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In this paper, the SBA-15 molecular sieve was prepared by hydrothermal method. Carvedilol was loaded in the SB A-1 5 with impregnation method and the loading capacity of carvedilol is 443.50 mg/g. By means of chemical analysis, powder X-ray diffraction and low-temperature nitrogen adsorption-desorption technique at 77 K, the products were characterized. The results showed that carvedilol guest molecules had been successfully encapsulated into the channels of SBA-15. A research of the slow release effect of carvedilol encapsulated in SBA-15 mesoporous material was studied in simulated body fluid. The drug cumulative release is 19.6 % in 1 h and release 99.3 % after 32 h and tended to tranquilization. The drug release has tended to tranquilization to 19.2% after 4 h in simulated gastric fluid and to 63.2 % after 8 h in simulated intestinal fluid.
机译:本文采用水热法制备了SBA-15分子筛。卡维地洛采用浸渍法负载在SB A-1 5中,卡维地洛的负载量为443.50 mg / g。通过化学分析,粉末X射线衍射和77 K下的低温氮吸附-脱附技术,对产物进行了表征。结果表明卡维地洛的客体分子已被成功包封到SBA-15通道中。在模拟体液中研究了SBA-15中孔材料中卡维地洛缓释作用的研究。药物在1小时内累积释放为19.6%,在32小时后释放99.3%,并趋于稳定。在模拟胃液中4 h后,药物释放趋于稳定,至19.2%,而在模拟肠液中8 h后,药物释放趋于63.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号